Today the Cannabis Regulatory Agency (CRA) issued an updated “Expectation for Maintenance of Standard Operating Procedures” Technical Bulletin to provide guidance and clarification on each licensee’s obligation to maintain SOPs

Indio, “The City of Festivals’”, long-anticipated application period for the regulation of cannabis storefront retail is quickly approaching. Starting September 1st, applicants can apply for one of the five coveted storefront retail licenses via an online application.

Alabama’s legalization of medical cannabis in May - coupled with Louisiana, Georgia and Mississippi expanding their programs this year - presents a second southeastern opportunity to cannabis companies that were shut out of Florida by that state’s decision to license only a handful of vertically integrated, seed-to-sale operators. At first glance, the four-state opportunity looks like it could be even bigger than Florida since their combined population is 23.6 million versus Florida’s 22 million.

Governor John Bel Edwards approved ten new cannabis bills in June including one measure that would expand the number of dispensaries (marijuana pharmacies) in Louisiana. The

Join this week's host, Sibusiso Xaba as he discusses the current legal cannabis space and potential markets with Mr. Motlatjo Makaepea, Chief Director of Agroprocessing and Economic Services at the Gauteng Province in South Africa.

New York adult-use legalization could prove to be a once-in-a-lifetime opportunity for local start-ups in what is the country’s fourth largest state by overall population, but the third largest in terms of adult cannabis consumers

Join our panel of industry experts for a lively discussion during the "Clinical Trials Within the Cannabinoid and Psychedelic Space" on July 13th at 10am PST.

Last month Rhode Island became the 19th state to legalize and regulate recreational cannabis, with the General Assembly overwhelmingly voting in favor of the legislation.

On February 2, 2022, Mississippi became the 37th state to allow cannabis for medical use.

This article provides an overview of the Alabama Compassion Act Bill and how to prepare if you intend to apply for an Alabama cannabis license.

Host:

Lolla Stovall, Counsel, Zuber Lawler

Moderator:

Janet Jackim, Partner, Zuber Lawler

Panelists:

Edward Ranger, Lawyer, Ranger Firm

Wes Reynolds, CEO, Green Mill Supercritical

James Eaves, VoltServer Inc.

Ivy Bader, Licensing and Compliance Manager, Global Go

Ryan Hurley, General Counsel, Copperstate Farms

Israel has long been a leader in cannabis in both medical research and its exciting marketplace. Join us for an inside look into Israel's medical cannabis market.

New York cannabis licenses not available until 2023— Here is what to do in the meantime.

Adult-use legalization was signed into law in New York March 31, 2021 (the 15th state to do so) and is now on the horizon in Germany after the Bundestag election (on September 26, 2021) that appears likely to bring a pro-legalization coalition to power. That has whetted cannabis investor appetite for the growth likely to follow since New York is the 4th largest US state (20.2 million population) and Germany is the largest country in Europe (83 million).

The value of the UK medical cannabis market is estimated to be more than £2 billion by 2024 if even half of the 1.4 million individuals currently sourcing cannabis illegally for medical reasons were to be granted a prescription. While the UK enjoys a reputation as a globally dominant medical cannabis producer, nearly all products prescribed in the UK are imports.

On September 15, the public comment period opened to provide feedback on the Department of Cannabis Control’s (“DCC”) recently released proposed emergency regulations. The Office of Administrative Law’s (“OAL”) 10-day review period will close Monday September 20, so it is imperative that all industry stakeholders participate and submit their comments before the review period closes.

The cannabis industry has been full of surprises in its short history, many of them caused by the unintended consequences of regulations. Some were positive surprises: During the 2020 second quarter COVID-19-lockdowns most regulators somewhat surprisingly decreed cannabis sales an essential service without much discussion. Many even allowed curbside pick-up and delivery for the first time to allow medical patients - and even adults coping with anxiety – safe access to their medication during the pandemic. Cannabis sales continued to boom while many sectors shrank.